首页> 外文期刊>Nucleic Acids Research >The PR-Set7 binding domain of Riz1 is required for the H4K20me1-H3K9me1 trans-tail 'histone code' and Riz1 tumor suppressor function
【24h】

The PR-Set7 binding domain of Riz1 is required for the H4K20me1-H3K9me1 trans-tail 'histone code' and Riz1 tumor suppressor function

机译:H4K20ME1-H3K9ME1跨尾“组蛋白代码”和RIZ1肿瘤抑制函数需要RIZ1的PR-Set7绑定域

获取原文
获取原文并翻译 | 示例
           

摘要

PR-Set7/Set8/KMT5a is the sole histone H4 lysine 20 monomethyltransferase (H4K20me1) in metazoans and is essential for proper cell division and genomic stability. We unexpectedly discovered that normal cellular levels of monomethylated histone H3 lysine 9 (H3K9me1) were also dependent on PR-Set7, but independent of its catalytic activity. This observation suggested that PR-Set7 interacts with an H3K9 monomethyltransferase to establish the previously reported H4K20me1-H3K9me1 trans-tail 'histone code'. Here we show that PR-Set7 specifically and directly binds the C-terminus of the Riz1/PRDM2/KMT8 tumor suppressor and demonstrate that the N-terminal PR/SET domain of Riz1 preferentially monomethylates H3K9. The PR-Set7 binding domain was required for Riz1 nuclear localization and maintenance of the H4K20me1-H3K9me1 trans-tail 'histone code'. Although Riz1 can function as a repressor, Riz1/H3K9me1 was dispensable for the repression of genes regulated by PR-Set7/H4K20me1. Frameshift mutations resulting in a truncated Riz1 incapable of binding PR-Set7 occur frequently in various aggressive cancers. In these cancer cells, expression of wild-type Riz1 restored tumor suppression by decreasing proliferation and increasing apoptosis. These phenotypes were not observed in cells expressing either the Riz1 PR/SET domain or PR-Set7 binding domain indicating that Riz1 methyltransferase activity and PR-Set7 binding domain are both essential for Riz1 tumor suppressor function.
机译:PR-Set7 / Set8 / KMT5A是唯一的组蛋白H4赖氨酸20单甲基转移酶(H4K20ME1)在美唑烷中,对于适当的细胞分裂和基因组稳定性至关重要。我们意外地发现,单甲基化组蛋白H3赖氨酸9(H3K9ME1)的正常细胞水平也取决于Pr-Set7,而是与其催化活性无关。该观察结果表明,PR-Set7与H3K9单甲基转移酶相互作用以建立先前报道的H4K20ME1-H3K9ME1跨尾'组蛋白代码'。在这里,我们表明PR-Set7具体而是直接结合Riz1 / PRDM2 / KMT8肿瘤抑制器的C-末端,并证明RIZ1的N-末端PR /设定结构域优先单甲基化物H3K9。 RIZ1核定位和维护H4K20ME1-H3K9ME1跨尾“组型代码”需要PR-Set7结合域。尽管Riz1可以用作阻遏物,但是Riz1 / H3K9ME1可分配用于抑制PR-Set7 / H4K20ME1调节的基因。导致截短的Riz1导致截短的Riz1不能在各种侵袭性癌症中经常发生截断的Riz1。在这些癌细胞中,通过降低增殖和增加的细胞凋亡,野生型RiZ1的表达恢复肿瘤抑制。在表达RIZ1 PR /设定结构域或PR-SET7结合结构域的细胞中未观察到这些表型表明,表明RIZ1甲基转移酶活性和PR-SETT7结合结构域均为RIZ1肿瘤抑制功能。

著录项

  • 来源
    《Nucleic Acids Research》 |2014年第6期|共10页
  • 作者单位

    Department of Biochemistry and Molecular Biology University of Southern California Keck School of Medicine Harlyne J. Norris Cancer Research Tower Los Angeles CA 90033 USA;

    Department of Biochemistry and Molecular Biology University of Southern California Keck School of Medicine Harlyne J. Norris Cancer Research Tower Los Angeles CA 90033 USA;

    Department of Biochemistry and Molecular Biology University of Southern California Keck School of Medicine Harlyne J. Norris Cancer Research Tower Los Angeles CA 90033 USA;

    Department of Biochemistry and Molecular Biology University of Southern California Keck School of Medicine Harlyne J. Norris Cancer Research Tower Los Angeles CA 90033 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号